» Articles » PMID: 38219910

The Impact of Transportation Mode, Socioeconomic Deprivation and Rurality on Travel Times to Radiotherapy and Surgical Services for Patients with Prostate Cancer: A National Population-based Evaluation

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2024 Jan 14
PMID 38219910
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The distances that patients have to travel can influence their access to cancer treatment. We investigated the determinants of travel time, separately for journeys by car and public transport, to centres providing radical surgery or radiotherapy for prostate cancer.

Methods: Using national cancer registry records linked to administrative hospital data, we identified patients who had radical surgery or radiotherapy for prostate cancer between January 2017 and December 2018 in the English National Health Service. Estimated travel times from the patients' residential area to the nearest specialist surgical or radiotherapy centre were estimated for journeys by car and by public transport.

Results: We included 13,186 men who had surgery and 26,581 who had radiotherapy. Estimated travel times by public transport (74.4 mins for surgery and 69.4 mins for radiotherapy) were more than twice as long as by car (33.4 mins and 29.1mins, respectively). Patients living in more socially deprived neighbourhoods in rural areas had the longest travel times to the nearest cancer treatment centres by car (62.0 mins for surgery and 52.1 mins for radiotherapy). Conversely patients living in more affluent neighbourhoods in urban conurbations had the shortest (18.7 mins for surgery and 17.9 mins for radiotherapy).

Conclusion: Travel times to cancer centres vary widely according to mode of transport, socioeconomic deprivation, and rurality. Policies changing the geographical configuration of cancer services should consider the impact on the expected travel times both by car and by public transport to avoid enhancing existing inequalities in access to treatment and patient outcomes.

Citing Articles

Cancer Patients' Views on Ultrahypofractionated Radiotherapy: A Questionnaire-Based Survey.

Kikuchi K, Segawa T, Oikawa H, Ieko Y, Nakamura R, Ariga H Cureus. 2024; 16(10):e72093.

PMID: 39575022 PMC: 11580106. DOI: 10.7759/cureus.72093.


Is Centralisation of Cancer Services Associated With Under-Treatment of Patients With High-Risk Prostate Cancer?-A National Population-Based Study.

Han L, Mayne E, Dodkins J, Sullivan R, Cook A, Parry M Cancer Med. 2024; 13(21):e70403.

PMID: 39526482 PMC: 11551782. DOI: 10.1002/cam4.70403.


Advancing the Collaboration Between Imaging and Radiation Oncology.

Jia X, Carter B, Duffton A, Harris E, Hobbs R, Li H Semin Radiat Oncol. 2024; 34(4):402-417.

PMID: 39271275 PMC: 11407744. DOI: 10.1016/j.semradonc.2024.07.005.


Changes in Time to Initial Physician Contact and Cancer Stage Distribution during the COVID-19 Pandemic in Patients with Head and Neck Squamous Cell Carcinoma at a Large Hungarian Cancer Center.

Szabo E, Kopjar E, Rumi L, Boronkai A, Bellyei S, Gyongyi Z Cancers (Basel). 2024; 16(14).

PMID: 39061209 PMC: 11274479. DOI: 10.3390/cancers16142570.


The Influence of Urbanization on the Patterns of Hepatocellular Carcinoma Mortality From 1999 to 2020.

Kusnik A, Najim M, Renjith K, Vyas C, Renjithlal S, Alweis R Gastroenterology Res. 2024; 17(3):116-125.

PMID: 38993549 PMC: 11236338. DOI: 10.14740/gr1743.